# LIPIDS-P Trial Phase I/II Trial

> **NCT03405870** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 59 (actual)

## Conditions studied

- Sepsis, Severe
- Septic Shock

## Interventions

- **DRUG:** Smoflipid

## Key facts

- **NCT ID:** NCT03405870
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-17
- **Primary completion:** 2023-04-26
- **Final completion:** 2023-04-26
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405870, "LIPIDS-P Trial Phase I/II Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03405870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*